Ownership history in Redmile Group, LLC · 16 quarters on record
This page tracks every 13F SEC filing in which Redmile Group, LLC reported a position in RAPT THERAPEUTICS INC (RAPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 885,927 | +333,333 | +60.3% | 2.21% | $30.0M | $33.87 |
| 2025 Q3 | REDUCED | 552,594 | -78,092 | -12.4% | 1.39% | $14.3M | $25.79 |
| 2025 Q2 | REDUCED | 630,686 | -5,844,631 | -90.3% | 0.54% | $5.0M | $8.00 |
| 2025 Q1 | UNCHANGED | 6,475,317 | — | 0% | 0.75% | $7.9M | $9.76 |
| 2024 Q4 | ADDED | 6,475,317 | +5,970,785 | +1183.4% | 0.71% | $10.2M | $12.64 |
| 2024 Q3 | REDUCED | 504,532 | -32,150 | -6.0% | 0.06% | $1.0M | $16.08 |
| 2024 Q2 | REDUCED | 536,682 | -125,716 | -19.0% | 0.10% | $1.6M | $24.40 |
| 2024 Q1 | ADDED | 662,398 | +295,622 | +80.6% | 0.22% | $5.9M | $71.84 |
| 2023 Q4 | REDUCED | 366,776 | -60,714 | -14.2% | 0.33% | $9.1M | $198.80 |
| 2023 Q3 | REDUCED | 427,490 | -4,429 | -1.0% | 0.34% | $7.1M | $132.96 |
As of 2025 Q4 — sorted by position size